Akela Pharma, Inc. (AKL.TO)
-Toronto 0.01 0.00(0.00%) Nov 22, 3:52PM EST
| Prev Close: | 0.01 |
|---|
| Open: | N/A |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 0.01 - 0.12 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | N/A |
|---|
| Market Cap: | 323.90k |
|---|
| P/E (ttm): | 0.03 |
|---|
| EPS (ttm): | 0.36 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in CAD.
Headlines
- No Headlines available for AKL.TO at this time.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 0.01 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Akela Pharma, Inc. operates as a specialty contract pharmaceutical formulation developer in the United States. It offers contract pharma services comprising formulation and process development of drug in tablets, capsules, multiparticulates, fast ...
View More 
0.08%